Clinical trial
Effect of Milrinone Versus Placebo on Hemodynamics in Patients With Septic Shock; Randomized Control Trial
NCT05122884 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Milrinone Versus Placebo on Hemodynamics in Patients With Septic Shock; Randomized Control Trial
- Lead sponsor
- Mahidol University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- December 1, 2021
- Completion date
- June 30, 2025
- Enrollment
- 64 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac output, septic shock